Sort
39,280 grants matching “leukemia”
Validation and Development of WEE1 as a therapeutic target in AML
$305,619Christopher C Porter · University Of Colorado Denver · R01 · FY2014 · CA
AAV-mediated targeted DNA integration in mouse ES cells
$305,563Ralph Michael Linden · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · GM
AAV-mediated targeted DNA integration in mouse ES cells
$305,563Ralph Michael Linden · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · GM
MECHANISMS BY WHICH IFN-GAMMA SEPARATES GVHD AND GVL
$305,562Yong-Guang Yang · Massachusetts General Hospital · P01 · FY2008 · CA
The Role Of CREB In Leukemogenesis
$305,543University Of California Los Angeles · R01 · FY2005 · HL
ACTIVATION OF IKB KINASE BY HTLV-I TAX
$305,543Pennsylvania State Univ Hershey Med Ctr · R01 · FY2003 · CA
Genetic Determinants of Cytomegalovirus Pathogenesis
$305,536Eastern Virginia Medical School · R01 · FY2005 · CA
Enhancement of methotrexate uptake in childhood ALL
$305,489John J McGuire · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
WUMC-Cancer and Leukemia Group B
$305,489Washington University · U10 · FY2003 · CA
Role of Nucleophosmin in FA-evolved Leukemia
$305,450Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2005 · CA
Nucleophosmin in Fanconi's Anemia-evolved Leukemia
$305,450Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2004 · CA
Genomic profiling of pathological R-loop formation in human diseases.
$305,428Frederic Louis Chedin · University Of California At Davis · R01 · FY2019 · GM
Functional identification of CLL drug response and resistance
$305,395Anthony G Letai · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Application of 454 Sequencing to Cancer Epigenomics
$305,392Huidong Shi · Augusta University · R33 · FY2011 · CA
Monocytes and the Intestinal Microbiota following ALLO-HSCT
$305,385Eric G Pamer · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Monocytes and the Intestinal Microbiota following ALLO-HSCT
$305,385Eric G Pamer · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Distinquishing the Afferent Sensitization of GVHD from GVL/GVT at the Level of H
$305,380James W. Young · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Distinquishing the Afferent Sensitization of GVHD from GVL/GVT at the Level of H
$305,380James W. Young · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Mechanisms of Leukemogenesis in Down Syndrome
$305,363John D Crispino · Northwestern University At Chicago · R01 · FY2009 · CA
ROLE OF THE PNH PHENOTYPE IN LEUKEMIC TRANSFORMATION
$305,362Barnes-Jewish Hospital · R01 · FY2001 · CA
In Vivo Selection of Transduced Hematopoietic Stem Cells
$305,351Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2008 · HL
SIGNAL TRANSDUCTION IN ERYTHROID CELLS
$305,316Children'S Hospital Boston · P01 · FY2000 · HL
Advanced Isotope Aided NMR For CB2 Structural Study
$305,285University Of Houston · R01 · FY2005 · DA
Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells
$305,284Ameeta Kelekar · University Of Minnesota · R01 · FY2015 · CA
MLL Fusions and cooperating mutations in acute leukemia
$305,279Michael J Thirman · University Of Chicago · R01 · FY2006 · CA